Amylin Pharmaceuticals
Pharmaceutical / Biotechnology
Companies / Amylin Pharmaceuticals
0
Latest Hiring Jobs
3
Clinical Trials
0
FDA Products
0
Publications
Company Overview
COMPANY TYPE
Unknown
INDUSTRIES
Unknown
HEADQUARTERS
WEBSITE
Not available
Clinical activity detected
This company has 3 clinical trial records in the intelligence database.
Clinical Development
Recent clinical trial activity
3 Trials
Trial Phase Status Enrollment Start Date Condition
NCT00806520
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
Observational COMPLETED - - Type 2 Diabetes
NCT00876213
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
Observational COMPLETED - - Diabetes
NCT00803920
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
Observational COMPLETED - - Type 2 Diabetes Mellitus
Company Intelligence
Company profile enrichment is not available yet.

Hiring Intelligence

Latest open positions detected for this company
View All Jobs
No current hiring positions found.
FDA Regulatory Intelligence
FDA product and regulatory signals
0 Signals
No FDA regulatory data available.